Radiolabeled compounds targeting the prostate-specific membrane antigen
US-2024018110-A1 · Jan 18, 2024 · US
US11548911B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11548911-B2 |
| Application number | US-202117170060-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 8, 2021 |
| Priority date | Aug 9, 2018 |
| Publication date | Jan 10, 2023 |
| Grant date | Jan 10, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a new building block for peptide synthesis, which introduces a cleavage site that can be used to generate cleavable fragments subsequent to a peptide sequence.
Opening claim text (preview).
The invention claimed is: 1. A method comprising: a) synthesizing a peptide on a first solid support, said peptide comprising a first terminal amino group, b) providing a building block comprising the structure: wherein 2≤n≤24, m=2 or 3, A is an acid labile protective group, and B is a tag or base labile protective group; and c) coupling said building block to said first terminal amino group of said peptide. 2. The method of claim 1 , wherein when B is a base labile protective group further comprising: c) removing the base labile protective group B from the building block to provide a deprotected amino group, and d) coupling at least one amino acid building block to the deprotected amino group of the building block, wherein the at least one amino acid building block comprises a second terminal amino group. 3. The method of claim 1 , wherein when B is a base labile protective group further comprising: c) removing the base labile protective group B from the building block to provide a deprotected amino group, e) optionally coupling at least one amino acid building block to the deprotected amino group of the building block, wherein the at least one amino acid building block comprises a second terminal amino group, and e) coupling a tag or a functional group to either (i) the second terminal amino group of the at least one amino acid building block, or (ii) the deprotected amino group of the building block. 4. The method of claim 3 , wherein said tag or functional group is selected from the group consisting of PEG, poly-lysine, poly-arginine, poly-glutamic acid, poly-aspartic acid, biotin, hydrazine, aminooxy, azide, alkynyl, alkenyl, aldehyde, pyrroloalanine, carboxy, and thiol. 5. The method of claim 1 , further comprising: removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support. 6. The method of claim 5 , further comprising: contacting said cleaved peptide with a buffer having a pH≥8. 7. The method of claim 3 , wherein said tag or functional group is a solubilizing tag, and wherein the method further comprises: g) removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support, h) purifying said cleaved peptide, and i) cleaving said solubilizing tag at a pH≥8. 8. The method of claim 3 , wherein said tag or functional group is an immobilizing tag, and wherein said method further comprises: g) removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support, h) immobilizing said cleaved peptide via said immobilizing tag on a second solid support, i) optionally conjugating said cleaved peptide to an additional chemical entity, and j) cleaving said immobilizing tag at a pH≥8. 9. The method of claim 8 , wherein said additional chemical entity is selected from the group consisting of a nucleic acid, an oligonucleotide, and a nucleotide. 10. The method of claim 9 , wherein said nucleotide is a nucleoside-hexaphosphate.
to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title
on carriers {(C07K1/003, C07K1/006 take precedence)} · CPC title
by chemical synthesis · CPC title
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.